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Abstract: Thirty-six Sprague Dawley male rats were housed in individual cages and randomly divided into six groups: control, copper
sulfate (Cu; 500 ppm body weight (BW)/day), flunixin meglumine (FM; 2.2 ppm BW/day), chrysin (chrysin; 50 ppm BW/day), copper
sulfate + FM (Cu + FM; 500 ppm BW/day of copper sulfate and 2.2 ppm BW/day of FM), and copper sulfate + chrysin (Cu + Chrysin;
500 ppm BW/day of copper sulfate and 50 ppm BW/day of chrysin). Feed intake (FI) in the Cu + Chrysin group significantly increased
in comparison with that of the Cu group (P < 0.01). Cu excess significantly increased malondialdehyde, indicating oxidative stress.
Chrysin and FM administration significantly decreased malondialdehyde levels and increased the superoxide dismutase and catalase
activities in the liver and kidney tissues (P < 0.001). Serum TNF-α levels were significantly lower in the Cu + FM and Cu + Chrysin
groups in comparison to the Cu group (P < 0.001). It was seen that FM and chrysin treatments alleviated degeneration, necrosis, and
apoptosis in the liver and kidney tissues of the Cu-treated rats. Chrysin appeared to ameliorate the adverse effects on FI and liver and
kidney tissues by scavenging where the free radicals are located and increasing the activity of antioxidants.
Key words: Antioxidant status, body weight change, chrysin, copper, flunixin meglumine, histological changes

1. Introduction
Continuous contamination with copper (Cu) is anticipated
because copper and its salts are extensively used in many
areas of industry and agriculture. Although copper is an
element involved in a variety of biological processes in life,
it can be toxic when it is in excess (1). Copper is related to
numerous processes responsible for normal development
and growth. It is the building block of cuproproteins, e.g.,
ceruloplasmin, tyrosinase, and superoxide dismutase
(2,3). It supports the function of numerous cellular
enzymes. Ions of Cu can be in different redox states,
reduced Cu(I), or oxidized Cu(II), permitting the metal
to play a basic role as a cofactor in cell physiology of
the redox chemistry of enzymes, elastin cross-linking,
mitochondrial respiration, and free radical scavenging
(4). On the other hand, Cu homeostasis disorders or the
accumulation of Cu in amounts that exceed metabolic
requirements of the organism can lead to negative effects
(5). Copper is a redox-active metal. The redox identity of
copper contributes to its potential toxicity (6). Copper can
induce oxidative stress by increasing the production of

reactive oxygen species (ROS), which causes peroxidative
degeneration of polyunsaturated fatty acids in membrane
lipids, and biomolecular damage (7,8). The liver is the
primary organ affected by copper-induced toxicity. Longterm use of Cu in rats may cause nephrotoxicity and renal
dysfunction (9).
Flunixin meglumine is one of many nonsteroidal
antiinflammatory drugs (NSAIDs) that are widely used and
prescribed by veterinarians. Antiinflammatory drugs are
effective in decreasing inflammation. Mouithys-Mickalad
et al. (10) reported that NSAIDs had the capacity to fight
against free radicals and had strong antioxidant effects.
On the other hand, NSAID use has considerable adverse
effects, including associated morbidity and mortality
(11). In a previous study, it was reported that there was
no clinical case report of flunixin meglumine overdoses,
which indicates that it may be a safe drug (12).
Flavonoids are natural polyphenols existing in plants.
Several studies showed that diets rich in flavonoids
prevent various diseases such as oxidative damage (13),
cancers (14), cardiovascular diseases (15), diabetes
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(16), and neurodegenerative diseases (17). Chrysin
(5,7-dihydroxyflavone) is a flavonoid that is found in
propolis, honey, and various plants (18,19). It has very
important biological properties such as antioxidant (20),
antiinflammatory (21), and anticancer (22) properties.
The present study was designed to examine the effects of
flunixin meglumine when it is used as an antiinflammatory
for the treatment of many diseases and of chrysin, having
the flavonoid structure, on the oxidative stress induced by
Cu in an animal model using male rats. Histopathological
studies were also carried out to assess the effects of flunixin
meglumine and chrysin on Cu damage to the rats’ livers
and kidneys.

decapitation. For biochemical analysis, we took 1.5 mL of
blood sample and liver and kidney tissues from each rat.
The samples were stored at −20 °C until the analyses were
completed.

2. Materials and methods
2.1. Drugs
Copper sulfate was purchased from Sigma. Chrysin
(Aldrich) and flunixin meglumine (50 mg/mL injectable
solution) were provided from commercial firms.
2.2. Animals, diet, and treatment
Thirty-six Sprague Dawley adult (250–300 g, 6–8 weeks
old) male rats were used in the experiment. We obtained
the rats from the Experimental Research Center of Fırat
University and housed them in stainless steel cages (40%–
60% humidity, 24 ± 3 °C, 12 h dark-light cycle). The rats
were fed with standard pellet feed, containing 2650 kcal/
kg metabolic energy and 23% crude protein (Elazığ Food
Company, Turkey). Drinking water was given ad libitum.
The present study was approved by the Animal Ethics
Committee of Fırat University (08.01.2014/No:15).
Animals were randomly divided into 6 groups and
housed in individual cages. Over a period of 21 days, rats in
group 1 served as the control group; those in group 2 (Cu)
were given copper sulfate at 500 ppm body weight (BW) per
day by gavage; those in group 3 (FM) were given flunixin
meglumine at 2.2 ppm BW per day by intraperitoneal (IP)
administration; those in group 4 (Chrysin) were given
chrysin at 50 ppm BW per day by gavage; those in group
5 (Cu + FM) were given 500 ppm BW per day of copper
sulfate by gavage and 2.2 ppm BW per day of flunixin
meglumine by IP administration; and those in group 6
(Cu + chrysin) were given 500 ppm BW per day of copper
sulfate and 50 ppm BW per day of chrysin by gavage.
Rats were individually weighed at the start of the study,
and then weekly to monitor BW. Additionally, feed intake
(FI) and body weight change (BWC) were determined on
days 7, 14, and 21 of the experiment. Flunixin meglumine
(23), copper sulfate (24,25), and chrysin (13) doses were
determined based on previous studies. Subacute toxicity
formed in the rats that were given copper sulfate.
2.3. Sample collection
One day after the last administration, the rats were
anesthetized by inhalation of diethyl ether and killed by

2.4.2. Reduced glutathione (GSH)
The GSH level was spectrophotometrically measured
at 412 nm (27). The contents of protein in the liver and
kidney were determined using bovine serum albumin as
the standard (28). Results were expressed as nmol/mg
protein.

2.4. Lipid peroxidation (LPO) and antioxidant analyses
2.4.1. Lipid peroxidation
The LPO levels were spectrophotometrically measured
at 532 nm (26) according to the concentrations of
thiobarbituric acid reactive substances and the amount
of malondialdehyde (MDA) produced was used as
index of LPO. 1,1,3,3-Tetraethoxypropane was used as
standard. The levels of MDA were expressed as nmol/mL
homogenate.

2.4.3. Catalase (CAT)
The CAT activities of the liver and kidney were detected
using Aebi’s method (29) that is based on the determination
of the rate constant (k) for the hydrogen peroxide
separation rate at 240 nm. Results of the CAT activity were
expressed as k/g protein.
2.4.4. Superoxide dismutase (SOD)
Measurements were performed using Sun et al.’s method.
(30). This method is based on the reduction of xanthine
oxidase, which produces nitro blue tetrazolium. The
results were spectrophotometrically evaluated at 560 nm
and expressed as percent inhibition/mg protein.
2.5. Serum tumor necrosis factor alpha (TNF-α)
Serum TNF-α was determined by enzyme-linked
immunosorbent assay using a commercial kit (ELISA,
Cat. No. E-EL-R0019). The samples were read using the
automated Triturus enzyme immunoassay analyzer at
450 nm (Grifols-Quest, Miami, FL, USA). The cytokine
quantities of samples were detected from standard
curves of recombinant cytokines according to the linear
regression method.
2.6. Histopathological and immunohistochemical (IHC)
analyses
For histological assessments, the kidney and liver tissues
were fixed in 10% formalin solution, dehydrated in a
graduated alcohol series, and then embedded in paraffin.
The tissue samples that were embedded in paraffin were cut
at a thickness of 5 µm, mounted on 1/4 shaven slides, and
stained with hematoxylin and eosin (H&E) for histological
examination according to the standard procedure (31).
The cells that underwent apoptosis in the tissues were
evaluated immunohistochemically by using the caspase
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method. The samples were mounted on polylysine-coated
slides for analysis. After deparaffinization and rehydration,
the samples were transferred to citrate buffer at pH 6.0 and
were kept in a microwave oven for 20 min. The samples
were then washed with phosphate buffered saline (PBS)
after they were cooled for 20 min at room temperature.
They were immersed in 0.3% hydrogen peroxide for 5 min,
washed with PBS, incubated with Ultra V block for 5 min
at room temperature, and then incubated with a primary
rabbit-polyclonal active caspase-3 antibody (Thermo
Scientific, CPP32, Ab-4, UK) for 1 h in a humidified
chamber at 37 °C. The sections were rinsed in PBS before
incubation with biotinylated goat antipolyvalent reagent
for 30 min at room temperature and were washed with
PBS. Then they were incubated in streptavidin peroxidase
for 30 min at room temperature and were washed with PBS.
Staining was completed after the substrate was incubated
with a 3.3’-diamino-benzidine-tetrahydrochloride (DAB)
chromogen (Thermo Scientific, Ultra Vision Detection
System Anti-polyvalent, HRP/DAB, UK) for 5–15 min
and then the slides were washed for 5 min with distilled
water. The slides were counterstained with Mayer’s
hematoxylin for 30 s, rinsed in tap water for 5 min
and dehydrated, and then mounted using an aqueous
mounting medium. The active caspase-3 kit was used
according to the manufacturer’s instructions. The routine
H&E tissue sections and the active caspase-3 activities
of the liver and kidney tissues were examined under a
binocular-headed light microscope with the feature of
photomicroscope (Olympus BX-51, Olympus Optical
Co., Ltd., Tokyo, Japan) and photographs were taken. The

active caspase-3 positive cells in the tissue sections were
stained a brown color and were evaluated by looking at the
staining intensity (−, none; +, slight; ++, moderate; +++,
strong) with a semiquantitative scoring system.
2.7. Statistical analysis
All data were expressed as means ± SEM. Using one-way
analysis of variance (ANOVA) and the post hoc Duncan
test, SPSS 21 for PC was used to determine whether there
were any statistically significant differences between
the group means (IBM Corp., USA). The results were
considered statistically significant when P < 0.05.
3. Results
In the present study, FI and BW of rats treated with Cu
were significantly decreased in comparison with those of
the control, Cu + FM, and Cu + chrysin groups during the
course of the experiment (P < 0.01; Table 1).
MDA, indicating oxidative stress, significantly
increased in the kidney and liver tissues of the group that
was given copper (P < 0.001; Tables 2 and 3). Chrysin
and flunixin meglumine administration significantly
decreased the MDA levels in the kidneys and liver (P <
0.001). The GSH levels in the liver (P < 0.001) and kidney
(P < 0.01) tissues of the Cu-administrated group were
found to be significantly lower than those of the rats in
the control, flunixin meglumine, and chrysin groups (P <
0.01). Flunixin meglumine and chrysin supplementations
to Cu groups significantly increased the GSH levels to be
similar to those of the control group (P < 0.01; Tables 2
and 3). Superoxide dismutase and CAT activities of the
kidney and liver tissues in the Cu group were found to be

FI

BWC

BW

Table 1. Effects of flunixin meglumine (FM) and chrysin on body weight (BW, g), body weight change (BWC, g/rat daily), and feed
intake (FI, g/rat daily) of the experimental group members.
Days

Control

Cu

FM

Chrysin

Cu + FM

Cu + chrysin

P

IW

251 ± 13.4

249.5 ± 16.8

249 ± 14.3

249.5 ± 17

248.8 ± 14.9

250.5 ± 8.3

NS

7

275.4 ± 14

265.3 ± 15.7

271.3 ± 17.6

272.7 ± 15.5

266.7 ± 14.3

269.4 ± 8.3

NS

14

291.5 ± 12.7

274.9 ± 17.6

286.6 ± 16.4

288.5 ± 14.5

277.5 ± 13.7

280.8 ± 4.3

NS

21

312.8 ± 13.9

285.4 ± 17.9

306.7 ± 16.4

309 ± 13.8

302.7 ± 15.2

300.4 ± 4.5

NS

1–7

4.07 ± 0.35

2.64 ± 0.5

3.72 ± 0.59

3.86 ± 0.36

2.98 ± 0.69

3.15 ± 0.42

NS
NS

8–14

2.29 ± 0.37

1.37 ± 0.32

2.18 ± 0.24

2.26 ± 0.42

1.54 ± 0.55

1.62 ± 0.58

15–21

3.04 ± 0.32a

1.5 ± 0.12b

2.89 ± 0.17a

2.93 ± 0.25a

2.73 ± 0.14a

2.80 ± 0.09a

**

1–21

3.09 ± 0.07

1.79 ± 0.21

2.89 ± 0.16

2.97 ± 0.26

2.26 ± 0.33

2.49 ± 0.19

**
NS

a

b

ab

a

ab

ab

1–7

22.74 ± 1.46

19.93 ± 1.08

22.56 ± 0.85

22.68 ± 0.67

20.40 ± 1.83

21.78 ± 1.06

8–14

23.33 ± 0.29a

17.41 ± 1.15c

22.56 ± 0.53a

22.92 ± 0.67a

19.2 ± 0.63bc

19.80 ± 0.79b

**

15–21

22.92 ± 0.84

16.83 ± 1.37

22.38 ± 1.06

22.44 ± 1.05

18.66 ± 0.55

bc

18.54 ± 2.17

**

1–21

22.99 ± 0.64a

18.06 ± 0.90c

22.50 ± 0.48a

22.68 ± 0.69a

19.42 ± 0,71bc

20.04 ± 1.04ab

**

a

c

ab

ab

bc

IW: Initial weight; a, b, c: mean values with different superscripts within a row differ significantly; NS: nonsignificant; **: P < 0.01
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significantly lower than those of all the other groups (P <
0.001; Tables 2 and 3).
The serum TNF-α level of the Cu group was
significantly higher (P < 0.001) than those of other groups.
Serum TNF-α levels were significantly lower in the Cu +
FM and Cu + Chrysin groups in comparison to the Cu
group (P < 0.001; Table 4).
The liver and kidney samples of the control rats and
those of the rats that were treated with flunixin meglumine
alone and chrysin alone showed no abnormalities (Figures
1 and 2). However, the livers of the Cu-supplemented
rats showed hepatocellular degeneration and necrosis.
Karyolysis and karyomegaly were observed in several
hepatocyte cells. Moreover, it was determined that Cu
exposure caused vasocongestion and dilatation in most
sinusoids, mononuclear inflammatory cell infiltrations in
periportal areas, dilatation with hyperemia and hyaline
residue in some central veins, disorganization in some
hepatic cord areas, and biliary duct proliferation in

some portal areas. The flunixin meglumine and chrysin
treatments alleviated these Cu-induced degenerative and
necrotic changes. In addition, regenerative changes such
as a double nuclei in many hepatocytes were observed
(Figure 1). The kidneys from the Cu-treated rats also
demonstrated degeneration and necrosis of mostly
the proximal and minority distal tubules in the cortex.
Swelling, karyomegaly, and karyolysis were observed
in epithelial cells of the proximal tubules. Epithelial cell
desquamation and hyaline cylinders in the lumen of some
of those as well as congestion were found in some proximal
tubules. Shrinkage, congestion, and thickening in the
basal membrane of some glomeruli located in the cortex
were also observed. Congestion and focal mononuclear
cell infiltration were found in blood vessels in interstitial
tissue of the cortex while dilatation and degeneration were
seen in Bowman’s capsules. The flunixin meglumine and
chrysin treatments decreased tubular degeneration and
necrosis and proved that the majority of changes in the

Table 2. Effects of flunixin meglumine (FM) and chrysin on MDA (nmol/mL homogenate), GSH (nmol/mg protein), SOD (%inhibition/
mg protein), and CAT (k/g protein) activities in the livers of the experimental group members.

Liver

Control

Cu

MDA

2.42 ± 0.13

GSH

19.07 ± 0.57

SOD

0.24 ± 0.01a

CAT

0.77 ± 0.02

c

FM

a

Cu + FM

2.15 ± 0.21

P

3.05 ± 0.19

***

9.80 ± 0.75

18.45 ± 1.85

17.82 ± 1.32

14.48 ± 1.13

13.90 ± 0.97

***

0.16 ± 0.01c

0.27 ± 0.02a

0.26 ± 0.02a

0.19 ± 0.01bc

0.20 ± 0.01ab

***

0.18 ± 0.01

0.73 ± 0.02

0.70 ± 0.03

0.30 ± 0.01

0.27 ± 0.01

***

c

a

d

2.94 ± 0.14

Cu + chrysin

2.23 ± 0.16

c

c

a

Chrysin

3.84 ± 0.16

a

ab

b

a

b

b

b

c

b

c

: Mean values with different superscripts within a row differ significantly; ***: P < 0.001.

a, b, c, d

Table 3. Effects of flunixin meglumine (FM) and chrysin on MDA (nmol/mL homogenate), GSH (nmol/mg protein), SOD (%inhibition/
mg protein), and CAT (k/g protein) activities in the kidneys of the experimental group members.

Kidneys

Control

Cu

MDA

6.06 ± 0.31

GSH

25.48 ± 2.39

SOD

0.27 ± 0.03a

CAT

0.68 ± 0.01

c

FM

a

Cu + FM

8.64 ± 0.26

***

22.13 ± 1.59

22.36 ± 1.79

17.62 ± 1.48

15.39 ± 1.91

**

0.10 ± 0.01c

0.25 ± 0.01a

0.23 ± 0.01a

0.17 ± 0.02b

0.16 ± 0.02b

***

0.14 ± 0.01

0.62 ± 0.01

0.65 ± 0.03

0.30 ± 0.01

0.25 ± 0.01

***

c

c

ab

a

8.51 ± 0.20

P

14.84 ± 0.86
c

6.69 ± 0.44

Cu + chrysin

6.71 ± 0.44

c

a

Chrysin

11.23 ± 0.27

a

b

ab

a

b

bc

b

c

b

: Mean values with different superscripts within a row differ significantly; **: P < 0.01; ***: P <0.001.

a, b, c

Table 4. Effects of flunixin meglumine (FM) and chrysin on TNF-α (pg/mL) levels of experimental groups.
Control
TNF-α

106.22 ± 2.65

Cu
c

FM

164.32 ± 5.26

a

Chrysin

114.43 ± 3.32

c

Cu + FM

114.44 ± 3.08

c

Cu + chrysin

129.62 ± 3.38

b

P

131.25 ± 2.49

b

***

: Mean values with different superscripts within a row differ significantly; ***: P < 0.001.

a, b, c
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A

B

C

D

E

F

Figure 1. Histopathological ﬁndings in the livers of the experimental group members. (A) Cu + FM treatment; double nuclei in many
hepatocytes (arrows) (H&E staining, magnification 100×). (B) Cu + chrysin treatment; double nuclei in many hepatocytes (arrows)
(H&E staining, magnification 100×). (C) Cu treatment alone; karyomegaly in hepatocyte (black arrows), karyolysis in hepatocyte (black
arrowheads), vasocongestion and dilatation in sinusoids (white arrowheads), dilatation with hyperemia and hyaline residue in central
veins (white arrows) (H&E staining, magnification 100×). (D) Control; normal liver histology (H&E staining, magnification 200×). (E)
Flunixin meglumine treatment alone; normal liver histology (H&E staining, magnification 200×). (F) Chrysin treatment alone; normal
liver histology (H&E staining, magnification 200×).
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A

B

C

D

E

F

Figure 2. Histopathological ﬁndings in the kidneys of the experimental group members. (A) Cu + FM treatment; decreased degenerative
and necrotic changes (H&E staining, magnification 200×). (B) Cu + chrysin treatment; decreased degenerative and necrotic changes
(H&E staining, magnification 200×). (C) Cu treatment alone; karyomegaly (small black arrow) and karyolysis (black arrowhead) in
epithelial cells of proximal tubules, epithelial cell desquamation in lumen of proximal tubule (big black arrow), shrinkage and congestion
in glomeruli (star), thickening in basal membrane of glomeruli (arrows), dilatation and degeneration in Bowman’s capsule (diamond)
(H&E staining, magnification 100×). (D) Control; normal kidney histology (H&E staining, magnification 200×). (E) Flunixin meglumine
treatment alone; normal kidney histology (H&E staining, magnification 200×). (F) Chrysin treatment alone; normal kidney histology
(H&E staining, magnification 200×).
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cortex had been caused by the Cu supplements and could
be reasonably counteracted with flunixin meglumine and
chrysin supplements (Figure 2). Apoptotic cells showing
strong positive reactions in the hepatocytes with mostly
the proximal and minority distal tubules when compared
to the control, flunixin meglumine alone, and chrysin
alone groups were encountered with Cu exposure.
Although the flunixin meglumine treatment reduced the
Cu-induced apoptotic cells and the staining intensities of
these apoptotic cells were moderate, the chrysin treatment
still increased the apoptotic cells (Figures 3 and 4) in the
liver and kidney tissues.
4. Discussion
Prolonged exposure to elevated concentrations of
copper may have detrimental effects (8). The results
of the present study demonstrate that a dose of 500
ppm BW Cu intake can have toxic effects from day 21.
Kornegay et al. (32) determined that feeding 200 mg/kg
Cu increased the growth rate and FI (P < 0.01) during 5
weeks of tests; 400 mg/kg Cu depressed growth and FI
after week 2 in weanling crossbred pigs (n = 216; 6.9 kg
initially). In another study (33), Chiou et al. found that
increasing dietary Cu supplements of 400, 500, and 600
ppm significantly lowered egg production and FI after 4
weeks in laying hens (P < 0.05). The daily FI of increased
Cu groups in their study (400, 500, and 600 ppm dietary
Cu) was 109, 107, and 97.8 g/hen, respectively (P < 0.004).
These results agree with the findings of the present study.
BW of the animals steadily exposed to Cu decreased, which
can be a predictor of poor general health (8). Treatment of
rats with antioxidant compounds partially alleviated the
negative effects of oxidative stress induced by Cu (8). The
effects of amelioration on performance of chrysin in mice
were connected to the flavonoids in its structure (34).
The present study demonstrated that BW and BWC
statistically increased when flunixin meglumine and
chrysin supplementation was administered to the rats that
were given Cu (P < 0.01). A similar study (35) found that
the BW of cyclosporin-A (CsA)-treated animals was lower
than that of the control group. The decrease in BW was
certainly due to a parallel decrease in FI, which followed
CsA implementation. These results agree with those of
the present study. However, as earlier studies (8,36,37)
have shown that flavonoids protect against Cu toxicity, an
excess of Cu in rats may cause LPO and damage of cellular
membranes. In the present study, the decrease in BWC
of the Cu + chrysin group could be connected with the
flavonoid content of chrysin. It could also be due to the
fact that flavonoids show characteristics of antioxidants,
which also were chelating with radicals or trace elements
(38).
Excessive copper in diet may cause damage to
the membranes and LPO in rats. Mladenović et al.
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(8) reported that LPO increased after incubation of
erythrocyte suspension with Cu2+ ions. The Cu+ ion was
generated by the reduction of Cu2+ in the presence of the
superoxide anion (O2•-), which catalyzed the formation
of hydroxyl radicals (OH) that readily initiate further
chemical reactions. Ozcelik et al. (39) reported that the
plasma MDA levels in rats given water containing copper
(100 µg/mL) were higher than those in the control group,
and the GSH levels in their livers were lower. Mladenović
et al. (8) noticed that flavonoids can block LPO owing to
their structure, thus enabling them to scavenge ROS as
electron- or hydrogen-donating compounds or to chelate
metal ions. Thus, they can be reformative in situations
of oxidative stress or increased metal concentrations (8).
Similar to our study, Sultana et al. (40) reported increases
in LPO of the cisplatin-treated group compared to that of
the control group, and also dose-dependent inhibition of
LPO by chrysin. They claimed that chrysin protected the
kidney from free radical damage by cleaning free radicals
produced by cisplatin toxicity. Flunixin meglumine and
chrysin supplementations in Cu administration increased
the GSH levels significantly to be like that of the control
group (P < 0.01; Tables 2 and 3). Superoxide dismutase and
CAT activities of kidney and liver tissues in the Cu group
were significantly lower than those of all the other groups
(P < 0.001). SOD, a cellular antioxidant, is one of the
several important antioxidant enzymes. It reacts rapidly
and is removed by CAT as it converts O2− into H2O2. It has
been reported that excessive Cu accumulation in the liver
decreases SOD activity and causes increased MDA levels
in liver homogenates and serum (41). Chrysin and flunixin
meglumine treatments partially ameliorate the Cu-induced
imbalance in the oxidant–antioxidant systems of the liver
and kidney tissues. Konyalioglu et al. (23) reported that
flunixin meglumine had antioxidant properties. The cause
of its ameliorative effects on the antioxidant status in
cases of Cu toxicities can be connected to its antioxidant
properties (23). Chrysin supplementation in rats treated
with Cu caused significant increases of CAT and SOD (P <
0.001; Tables 2 and 3).
Ciftci et al. (42) suggested that the serum TNF-α levels
in the group that was given 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD) were significantly higher (P < 0.05)
when compared to those in other groups on day 15. The
TNF-α levels of the curcumin + TCDD group (60.81
pg/mL) decreased significantly in comparison to those
of the TCDD group (104.0 pg/mL). These results were
similar to ours. Lee et al. (43) noted that TNF-α induced
the activation of many transcriptional factors, which had
long been considered a prototypical proinflammatory
signaling pathway, through TNF-α receptor-dependent
signaling pathways. Flavonoids are widely used to inhibit
the activation of NF-κB, and they inhibit the expression
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Figure 3. Immunohistochemical findings in the livers of the experimental group members. (A) Cu + FM treatment; decreased numbers
of strong immunopositive cells for active caspase-3 with the moderate staining intensities (IHC, Mayer’s hematoxylin counterstain,
magnification 200×). (B) Cu + chrysin treatment; many apoptotic cells showing strong immunoreaction for active caspase-3 (IHC,
Mayer’s hematoxylin counterstain, magnification 100×). (C) Cu treatment alone; many apoptotic cells showing strong immunoreaction
for active caspase-3 (IHC, Mayer’s hematoxylin counterstain, magnification 200×). (D) Control; no immunoreactivity for active caspase-3
antibody (IHC, Mayer’s hematoxylin counterstain, magnification 100×). (E) Flunixin meglumine treatment alone; no immunoreactivity
for active caspase-3 antibody (IHC, Mayer’s hematoxylin counterstain, magnification 100×). (F) Chrysin treatment alone; a few active
caspase-3 positive apoptotic cells (IHC, Mayer’s hematoxylin counterstain, magnification 100×).
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Figure 4. Immunohistochemical findings in the kidneys of the experimental group members. (A) Cu + FM treatment; decreased numbers
of cells showing strong positive immunoreaction in tubules for active caspase-3 with moderate staining intensities (IHC, Mayer’s
hematoxylin counterstain, magnification 100×). (B) Cu + chrysin treatment; many apoptotic cells showing strong immunoreaction in
a large number of tubules for active caspase-3 (IHC, Mayer’s hematoxylin counterstain, magnification 100×). (C) Cu treatment alone;
many apoptotic cells showing strong immunoreaction in a large number of tubules for active caspase-3 (IHC, Mayer’s hematoxylin
counterstain, magnification 100×). (D) Control; no immunoreactivity for active caspase-3 antibody (IHC, Mayer’s hematoxylin
counterstain, magnification 200×). (E) Flunixin meglumine treatment alone; a few active caspase-3 positive apoptotic cells in tubules
(IHC, Mayer’s hematoxylin counterstain, magnification 200×). (F) Chrysin treatment alone; a few active caspase-3 positive apoptotic
cells in tubules (IHC, Mayer’s hematoxylin counterstain, magnification 200×).
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of proinflammatory genes in response to inflammatory
mediators such as TNF-α. Flunixin meglumine and chrysin
administration to rats that were given Cu decreased the
TNF-α level (Table 4). This may be due to the flavonoid
content structure of chrysin and the antiinflammatory
properties of flunixin meglumine that decreased the
TNF-α levels (43–45).
The histopathological changes induced by Cu
treatment include confirmed antioxidant status and
TNF-α levels. Similarly, Abu-Zinadah et al. (6) noted that
•
OH, which is produced through the biochemical reaction
of excess Cu, was believed to be responsible for devastating
cellular damage, including LPO. Copper excess causes
damage to liver and kidney tissues. Babaknejad et al. (9)
reported that Cu excess toxicity was closely correlated to
renal dysfunction. They also stated that tubular necrosis
and cellular pleomorphic adenoma were reported in rats
that had received excessive amounts of Cu. One of the
most toxic effects of Cu on kidneys is proteinuria (46).
Moreover, the liver damage induced by Cu decreases
serum protein (47). The livers from the Cu-supplemented
rats showed hepatocellular degeneration and necrosis.
The flunixin meglumine and chrysin treatments
alleviated the Cu-induced degenerative, necrotic, and
hemorrhagic changes (Figure 1). Moreover, the kidneys
from the Cu-treated rats demonstrated degeneration and
necrosis of mostly proximal and minority distal tubules
in the cortex. The flunixin meglumine and chrysin
treatments decreased tubular degeneration and necrosis
and proved that the majority of changes in the cortex
had been caused by the Cu supplements and could be
reasonably counteracted with flunixin meglumine and
chrysin supplements (Figure 2). Apoptotic cells showing
strong positive reactions in the hepatocytes with mostly
proximal and minority distal tubules when compared to
the control, flunixin meglumine alone, and chrysin alone
groups were encountered with Cu exposure. Although
the flunixin meglumine treatment reduced the number of
Cu-induced apoptotic cells, and the staining intensities of
these apoptotic cells were moderate, the chrysin treatment

still increased the apoptotic cells (Figures 3 and 4) in the
liver and kidney tissues. Rana (48) reported that, when
administrating Cu, ROS may be produced by the liver. The
liver toxicity might be associated with the LPO formation
and induction of oxidative damage. In some studies
(38,48), lipid peroxidation of mitochondrial membranes
of liver cells and MDA in the livers of Cu-loaded rats were
reported. In another study (49), apoptosis and necrosis
were found in the kidney and liver tissues in experimental
Cu toxicity in rats, as in our study. Treatments of chrysin
and flunixin meglumine modulated the toxic effects of Cu
in histopathological examinations of the liver and kidney
tissues (Figures 1 and 2). The reason for this may simply
be the strong antioxidant properties of chrysin (50) and
flunixin meglumine (23). Xuan et al. (50), determined
that chrysin in anticancer treatment significantly activated
caspase-3, which showed that chrysin-induced apoptosis
inhibits the proliferation of MCF-7 cells. Similarly, Kasala
et al. (34) reported the ability of chrysin to inhibit cell
proliferation, inflammation, and tumor development.
These findings confirm the chemopreventive potential of
chrysin against Cu toxicity in rats, as shown in our study
(Figures 3 and 4). We determined that chrysin, which is
rich in antioxidants (51,52), could be used to prevent the
adverse effects on the liver and kidney tissues resulting
from the toxicity of Cu.
In conclusion, chrysin, a natural bee product, appeared
to ameliorate adverse effects on feed intake and liver and
kidney tissues caused by Cu toxicity by increasing the
antioxidant activities and scavenging the free radicals.
Flunixin meglumine is a product that is not natural and has
side effects. Chrysin supplementation instead of flunixin
meglumine may be used as a good option to diminish the
negative effects of Cu on rats. Chrysin may be used for
treatment of some diseases that cause necrosis in the liver
and kidneys. This subject calls for further research.
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